Methylprednisolone Completed Phase 4 Trials for Ophthalmopathy, Thyroid-Associated Treatment

IndicationsStatusPurposePhase
CompletedTreatment4
clinicaltrials.gov IdentifierTitleDrugs
NCT0394819199Tc-MDP for Thyroid-Associated Ophthalmopathy